1. Vasilyeva I.А., Voronin E.E., Pokrovskiy V.V., Аksenova V.А., BagdasaryanT.R., Baryshnikova L.А., Valiev R.Sh., Viktorova I.B., ZagdynZ.M., ZiminaV.N., Kazimirova N.E., Karpina N.L., Kayukova S.I., KlevnoN.I., Kononchuk O.N., Kravchenko А.V., Larionova E.E., MaryandyshevА.O., MikhaylovskiyА.M., Morozova T.I., Okhtyarkina V.V., Panteleev А.M., Samoylova А.G., Sevastyanova E.V., Sinitsyn M.V., Skornyakov S.N., Stakhanov V.А., Chernousova L.N., Ergeshov А.E., Yurin O.G. Federalnye klinicheskie rekomendatsii po diagnostike i lecheniyu tuberkuleza u bolnykh VICH-infektsiey. [Federal clinical recommendations on diagnostics and treatment of tuberculous in HIV patients]. Moscow, 2016, 42 p. http://roftb.ru/netcat_files/doks2016/rec2016.pdf.
2. Kaminskiy G.D., Kudlay D.А., Panova А.E., Parolina L.E., Peregudova А.B., Pshenichnaya N.Yu., Samoylova А.G., Testov V.V., Tinkova V.V. Taktika vracha pri vyyavlenii, diagnostike i profilaktike sochetannoy infektsii VICH i tuberkulez: prakticheskoe rukovodstvo [Tactics of the physician in the detection, diagnosis and prevention of TB/HIV coinfection. Practical guide]. I.A. Vasilyeva, eds., Moscow, 2020, 152 p.
3. Kachanova А.А., Pimenova Yu.А., Shuev G.N., Аkmalova K.А., Sozaeva Zh.А., Krasnova N.M., Grishina E.А., Sychev D.А. The influence of polymorphic markers of the NAT2 gene on the risk of adverse reactions in patients with pulmonary tuberculosis treated with isoniazid and rifampicin. Bezopasnost i Risk Farmakoterapii, 2021, vol. 9, no. 1, pp. 25-33. (In Russ.)
4. Popov S.А., Sabgayda T.P., Radina T.S. Assessment of correlation between HIV infection and tuberculosis with multiple drug resistance. Tuberculosis and Lung Diseases, 2018, vol. 96, no. 7, pp. 25-32. (In Russ.)
5. WHO consolidated guidelines on drug-resistant tuberculosis treatment. Copenhagen, Regional Office for Europe, WHO, 2019, License CC BY-NC-SA 3.0 IGO. (In Russ.)